Soros Fund Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Soros Fund Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-75,000	Closed	-$18.8M	–	207
2018 Q1	$18.8M	Buy	+75,000	New	+$19.1M	0.3%	77
2017 Q1	–	Sell	-2,200	Closed	-$401K	–	273
2016 Q4	$401K	Buy	+2,200	New	+$375K	0.01%	155
2015 Q4	–	Sell	-2,200	Closed	-$295K	–	250
2015 Q3	$295K	Buy	+2,200	New	+$317K	﹤0.01%	217

Other funds holding BIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Soros Fund Management's BIO Position: Q2 2018 in Review

Soros Fund Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2018, closing a stake of 75,000 shares — an estimated $18.8M sold.

Soros Fund Management first reported a position in BIO in Q3 2015 and held it in 3 quarters. The position peaked at $18.8M in Q1 2018. 326 funds tracked by Wall St. Rank hold BIO as of Q2 2018.

Soros Fund Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2018 after selling out during the quarter.
Soros Fund Management sold 75,000 Bio-Rad Laboratories Class A shares in Q2 2018, an estimated $18.8M.
Soros Fund Management first reported a position in Bio-Rad Laboratories Class A in Q3 2015 and held it in 3 quarters.
Soros Fund Management's Bio-Rad Laboratories Class A position peaked at $18.8M in Q1 2018.
326 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2018.

Based on Soros Fund Management's 13F filing for Q2 2018, filed 14 Aug 2018.